Dark Forest Capital Management LP United Therapeutics Corp Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $286,922 - $401,033	1,257 New	1,257 $400,000
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $2.35 Million - $3.2 Million	11,407 Added 47529.17%	11,431 $3.18 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $4,879 - $5,860	24 New	24 $5,000
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $4,370 - $6,028	-25 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$166.16 - $213.96 $3,655 - $4,707	22 Added 733.33%	25 $4,000
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $14,745 - $17,286	-80 Reduced 96.39%	3 $1,000
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $14,928 - $17,835	83 New	83 $15,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.